By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Celldex Therapeutics, Inc. 

222 Cameron Drive
Suite 400
Phillipsburg  New Jersey  08865  U.S.A.
Phone: 908-454-7120 Fax: 908-454-1911



Company News
ESMO 2016 Takeaways: Don't Miss Celldex (CLDX), Exelixis (EXEL) and Tesaro (TSRO) 10/12/2016 6:18:55 AM
Celldex (CLDX) Release: Phase II Study Of Single-Agent Glembatumumab Vedotin In Patients With Checkpoint-Refractory Metastatic Melanoma Meets Primary Overall Response Endpoint And Demonstrates Clinically Meaningful Duration Of Response 10/10/2016 8:58:55 AM
Celldex (CLDX) Who? 2 Not-as-Risky Stocks That Shot Up in the Past Year 10/4/2016 6:24:16 AM
Celldex (CLDX) To Present At The Leerink Partners Rare Disease & Immuno-Oncology Roundtable 9/26/2016 8:02:24 AM
Celldex (CLDX) Appoints Elizabeth Crowley As Chief Product Development Officer 8/11/2016 11:06:25 AM
Celldex (CLDX) Reports Second Quarter 2016 Results 8/9/2016 11:10:41 AM
Celldex (CLDX) To Report Second Quarter 2016 Financial Results And Host Corporate 2016 Objectives Update Call 8/3/2016 10:56:17 AM
3 Biotech Stocks That Could Explode in the Next 12 Months 7/20/2016 6:56:36 AM
Celldex (CLDX) Initiates Phase I/II Clinical Trial Of New Product Candidate CDX-014 In Advanced Renal Cell Carcinoma 7/12/2016 7:52:34 AM
3 Bargain Basement Biotech Stocks That Have the Potential to Skyrocket 6/29/2016 8:26:37 AM